Ignite Creation Date:
2024-05-05 @ 5:12 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00406835
Status:
COMPLETED
Last Update Posted:
2006-12-04
First Post:
2006-11-30
Brief Title:
Prospective Randomized Trial Between WBRT Plus SRS Versus SRS Alone for 1-4 Brain Metastases
Sponsor:
Hokkaido University Hospital
Organization:
Hokkaido University Hospital
Study Overview
Official Title:
Phase 3 Study of Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for 1-4 Brain Metastases
Status:
COMPLETED
Status Verified Date:
2006-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if WBRT combined with SRS resulted in improvements in survival brain tumor control functional preservation rate and frequency of neurologic death
Detailed Description:
Whole-Brain Radiation Therapy WBRT had been a mainstay in the treatment of brain metastases However treatment strategy which rely on Stereotactic Radiosurgery SRS has becoming popular in Japan It is not well understood if the Whole-Brain Radiation Therapy WBRT combined with Stereotactic Radiosurgery SRS resulted in improvements in survival brain tumor control functional preservation rate and frequency of neurologic death In orer to determine the role of WBRT we conducted prospective randomized trial between WBRTSRS and SRS-alone for 1-4 brain metastatic patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None